Logo image of PMAX

POWELL MAX LTD-CL A (PMAX) Stock Fundamental Analysis

NASDAQ:PMAX - Nasdaq - VGG7200G1000 - Common Stock - Currency: USD

0.412  +0.03 (+8.42%)

After market: 0.4012 -0.01 (-2.62%)

Fundamental Rating

1

Overall PMAX gets a fundamental rating of 1 out of 10. We evaluated PMAX against 235 industry peers in the Capital Markets industry. Both the profitability and financial health of PMAX have multiple concerns. PMAX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

PMAX had negative earnings in the past year.
PMAX had a negative operating cash flow in the past year.
PMAX Yearly Net Income VS EBIT VS OCF VS FCFPMAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

PMAX has a worse Return On Assets (-28.57%) than 91.06% of its industry peers.
PMAX has a Return On Equity of -85.71%. This is amonst the worse of the industry: PMAX underperforms 88.94% of its industry peers.
Industry RankSector Rank
ROA -28.57%
ROE -85.71%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PMAX Yearly ROA, ROE, ROICPMAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

PMAX has a Gross Margin of 38.89%. This is in the lower half of the industry: PMAX underperforms 66.81% of its industry peers.
The Profit Margin and Operating Margin are not available for PMAX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PMAX Yearly Profit, Operating, Gross MarginsPMAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 0 20 -20 40 -40

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, PMAX has about the same amount of shares outstanding.
PMAX has a better debt/assets ratio than last year.
PMAX Yearly Shares OutstandingPMAX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M
PMAX Yearly Total Debt VS Total AssetsPMAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of 1.47, we must say that PMAX is in the distress zone and has some risk of bankruptcy.
PMAX's Altman-Z score of 1.47 is fine compared to the rest of the industry. PMAX outperforms 61.70% of its industry peers.
A Debt/Equity ratio of 0.91 indicates that PMAX is somewhat dependend on debt financing.
The Debt to Equity ratio of PMAX (0.91) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Altman-Z 1.47
ROIC/WACCN/A
WACCN/A
PMAX Yearly LT Debt VS Equity VS FCFPMAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

PMAX has a Current Ratio of 1.45. This is a normal value and indicates that PMAX is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.45, PMAX perfoms like the industry average, outperforming 59.15% of the companies in the same industry.
A Quick Ratio of 1.45 indicates that PMAX should not have too much problems paying its short term obligations.
The Quick ratio of PMAX (1.45) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 1.45
PMAX Yearly Current Assets VS Current LiabilitesPMAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for PMAX have decreased strongly by -353.70% in the last year.
PMAX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -26.53%.
EPS 1Y (TTM)-353.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-26.53%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PMAX Yearly Revenue VS EstimatesPMAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 10M 20M 30M 40M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

PMAX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PMAX Price Earnings VS Forward Price EarningsPMAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PMAX Per share dataPMAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PMAX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

POWELL MAX LTD-CL A

NASDAQ:PMAX (7/22/2025, 8:00:00 PM)

After market: 0.4012 -0.01 (-2.62%)

0.412

+0.03 (+8.42%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.5%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.06M
AnalystsN/A
Price TargetN/A
Short Float %3.01%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.76
P/FCF N/A
P/OCF N/A
P/B 2.88
P/tB 2.88
EV/EBITDA N/A
EPS(TTM)-0.17
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.23
BVpS0.14
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -28.57%
ROE -85.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.89%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 33.56%
Cap/Sales 4.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.45
Quick Ratio 1.45
Altman-Z 1.47
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-353.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-26.53%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-309.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-283.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-254.71%
OCF growth 3YN/A
OCF growth 5YN/A